This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

InTech Partners With The American Society For Exosomes And Microvesicles To Publish Exosomes And Microvesicles Journal, An Open Access Publication





RIJEKA, Croatia, April 8, 2013 /PRNewswire/ -- InTech Open Access publisher is pleased to announce the collaboration with the American Society for Exosomes and Microvesicles (ASEMV) to publish the scientific journal Exosomes and Microvesicles, a peer-reviewed publication designed to bring together exosomes principles, scientific research and clinical applications. The Exosomes and Microvesicles journal is one of the first publications to focus exclusively on this subject matter, which has important implications for treating diseases such as cancer.

Despite the past decade's explosion of research within the fields of exosomes, microvesicles and other extracellular vesicles, access to this data is often limited – thus impacting further advancements in human health. As the official journal of the ASEMV, Exosomes and Microvesicles will provide open access to global data, supporting the organization's mission to advance extracellular vesicle research and support the scientists, institutions and laboratories working in this field.

"The goal of Exosomes and Microvesicles is to connect scientists, clinicians and industry-based researchers, enhancing the translation of exosomes and their biology into clinical trials," said Douglas Taylor, ASEMV Secretary-General and Exosomes and Microvesicles editor. "No other current journal focuses on the application of exosomes in the maintenance of health and development of disease."

Exosomes and Microvesicles editors include experts and leaders in these research fields, who provide peer-review for all data submitted to the journal. Exosomes and Microvesicles' promise of excellence is evident in its Associate Editors and members of its Editorial Board: international experts with diverse expertise mirroring the journal's scope. Editors include:

  • Stephen J. Gould , ASEMV Acting President, Johns Hopkins University, Baltimore, USA
  • Douglas Taylor , ASEMV Secretary-General, Louisville, USA
  • Winston Patrick Kuo , Harvard Medical School, Boston, USA
  • Antonio Chiesi , Exosomics Siena SpA, Siena, Italy

Exosomes and Microvesicles will provide global access to high-impact research with novel contributions to the growing body of data around exosomes, microvesicles and other secreted vesicles. All accepted papers will undergo peer review and will be published in an open-access electronic format, with no charge to journal readers.

"As part of the launch of Exosomes and Microvesicles, InTech and ASEMV are currently waiving all submission fees for potential authors," said Winston Patrick Kuo, Harvard Medical School and Exosomes and Microvesicles editor. "Our goal is to remove access barriers to new, important research and globalize the scientific dialog. Through this new journal and its open access platform, we hope to provide the science community an international connection to cutting-edge research and potential new health solutions."

Research Categories Several categories of papers will be published, including original research articles, methods, review articles, hypothesis and opinions, letters to the Editors and meeting reports. Submissions are encouraged from all institutions and researchers working on topics related to extracellular vesicles, including:

  • Biogenesis of extracellular vesicles, both in eukaryotic and prokaryotic cells
  • Mechanisms of vesicle: cell interactions
  • Intercellular signaling
  • Intercellular traffic of proteins, nucleic acids and other macromolecules
  • Modulation of the extracellular matrix:
    • Roles of extracellular vesicles in normal physiological processes, including differentiation, development, immunity, tissue repair, stem cell biology, etc.
    • Roles of extracellular vesicles in disease, including cancer, diabetes, neurodegeneration, aging, HIV/AIDS, etc.
  • Virology and bacteriology
  • Biomarkers
  • Technical advances in vesicle purification and characterization
  • Design and production of cell derived vesicles
  • Design and production of synthetic vesicles
  • Use of extracellular vesicles in:
    • Diagnostics and companion diagnostics
    • Therapeutics delivery
    • Antigen presentation and vaccine development
    • Cell free regenerative medicine
    • Association with other synthetic nanoparticle for different scopes

About the American Society for Exosomes and Microvesicles The ASEMV is a non-profit scientific society dedicated to advancing exosome and microvesicle research, promoting interactions among exosome/microvesicle researchers, and educating scientists, funding agencies and policy makers about the biological, biomedical and biotechnological importance of secreted vesicles.

About InTech InTech is an Open Access publisher within the fields of Science, Technology and Medicine (STM). Established in 2004, the company is one of the earliest pioneers of open access and has since become one of the fastest growing publishers in the world today.

With offices located in Central Europe, InTech works with authors, editors and societies on a global scale to publish the latest advances in theories and application of some of the most exciting research areas in STM, all to be accessed freely online.

Media Contact: Ana Nodilo nodilo@intechopen.com +385 51 688 994



1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
SYM TRADE IT LAST %CHG

Markets

DOW 17,841.98 -86.22 -0.48%
S&P 500 2,080.15 -9.31 -0.45%
NASDAQ 4,919.6440 -19.6830 -0.40%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs